A new nonaddictive pain relief method for musculoskeletal disorders
Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain
This study is testing a new way to relieve pain for people with muscle and joint issues by using a special gel that releases a safe, non-addictive medication right where it hurts, helping to manage pain without the risks of traditional opioids.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10881885 on NIH RePORTER |
What this research studies
This research focuses on developing a novel pain relief method for musculoskeletal disorders using a nonaddictive opioid prodrug. The approach involves creating a thermoresponsive hydrogel that releases the prodrug locally at the site of pain, providing sustained relief without affecting the spinal cord or brain. This method aims to minimize the risks associated with traditional opioids, such as addiction and dependency, while still delivering effective pain management. Patients will receive localized treatment that avoids systemic exposure, enhancing safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from acute or chronic musculoskeletal pain, particularly those who may be at risk for opioid dependency.
Not a fit: Patients who do not experience musculoskeletal pain or have contraindications to opioid use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer alternative to traditional opioids for managing musculoskeletal pain.
How similar studies have performed: Other research has shown promise in developing nonaddictive pain relief methods, but this specific approach using a thermoresponsive prodrug is relatively novel.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Wang, Dong — University of Nebraska Medical Center
- Study coordinator: Wang, Dong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.